American Society of Clinical Oncology

American Society of Clinical Oncology - ASCO

Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse. World's leading professional organization for oncology professionals caring for people with cancer. As a non-profit organization, ASCO is dedicated to achieving its charitable mission outlined by the organization's founders in 1964. ASCO strongly supports all types of cancer research, in particular, patient-oriented clinical research. ASCO is committed to: -Improving cancer care and prevention -Advancing the education of physicians and other professionals in the care of patients with cancer and supporting the development of clinical cancer researchers; -Fostering communication among cancer-related medical subspecialties and the exchange of a wide range of ideas related to cancer, including its biology, prevention, diagnosis, staging, treatment, and psychosocial impact. -Advocating public policy that ensures patient access to high-quality cancer care and that supports increased clinical cancer research; and -Assisting oncologists in addressing the challenges of the modern-day practice of oncology.
136180380
IČO
1965
Založeno
asco.org
Web
ASCO
Twitter (148192)
ASCOCancer
Facebook (76000)
29784
Návštěvnost

Novinky

Poslední komentáře

❤️ Grateful for organizations like ASCO that are dedicated to advancing cancer research and improving the lives of patients! Together, we can make a difference! #ASCOAdvocacy
detail
🌟 Excited to see the upcoming ASCO Annual Meeting! It's a great opportunity for professionals to share knowledge and innovate in cancer care. Let's work together for a cancer-free future! #CancerResearch
detail

Poslední diskuze

What strategies can the American Society of Clinical Oncology implement to enhance patient advocacy and engagement in cancer care?
Odpovědí: 3, Naposledy před 1 den detail
How can we better integrate the latest research findings from ASCO meetings into clinical practice to improve patient outcomes in oncology?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
American Society of Clinical Oncology logo
American Society of Clinical Oncology
+ Sledovat
520
Employee
4125
Volunteer
4.5
Reviews
Místo
O společnosti

- G30 -

Sign in or create account Search Abstracts and Presentations Discover Upcoming ASCO Meetings Benefits of an ASCO Membership Important Dates MEETING 2025 ASCO Annual Meeting May 30 Jun 04 2025 Online InPerson Chicago IL Early Registration Deadline April 23 2025 SAVE THE DATE Best of ASCO Jul 11 Jul 13 2025 Online InPerson Minneapolis MN SAVE THE DATE Quality Care Symposium Oct 10 Oct 12 2025 Online InPerson Chicago IL Most Viewed Videos Slides ASCO Plenary Series Results from the randomized phase III DREAMM7 study of belantamab mafodotin belamaf bortezomib and dexamethasone BVd vs daratumumab bortezomib and dexamethasone DVd in relapsedrefractory multiple myeloma RRMM. First Author MariaVictoria Mateos PhD Abstract 2025 ASCO Genitourinary Cancers Symposium Mevrometostat PF06821497 an enhancer of zeste homolog 2 EZH2 inhibitor in combination with enzalutamide in patients with metastatic castrationresistant prostate cancer mCRPC A randomized doseexpansion study. First Author Michael Schweizer Poster 2022 ASCO Annual Meeting Time to response duration of response and patientreported outcomes PROs with daratumumab DARA plus lenalidomide and dexamethasone DRd versus lenalidomide and dexamethasone Rd alone in transplantineligible patients with newly diagnosed multiple myeloma NDMM Subgroup analysis of the phase 3 MAIA study. First Author Thierry Facon Journal Journal of Clinical Oncology ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law First Author Rebecca A.

Rakovina
23 Vacancy More Detail